Wells Fargo’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Wells Fargo’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-69	Closed	–	–	7871
2022 Q3	$0	Sell	69 -20	-22%	-$7	﹤0.01%	7819
2022 Q2	$0	Buy	89 +7	+9%	+$3	﹤0.01%	7915
2022 Q1	$0	Buy	82 +19	+30%	+$18	﹤0.01%	8230
2021 Q4	$0	Buy	63 +14	+29%	+$42	﹤0.01%	8151
2021 Q3	$0	Buy	+49	New	+$252	﹤0.01%	7810
2021 Q2	–	Sell	-2,188	Closed	-$18K	–	7744
2021 Q1	$18K	Buy	+2,188	New	+$22.9K	﹤0.01%	6195

Other funds holding SCPS

MRCM

M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return

Wells Fargo's SCPS Position: Q4 2022 in Review

Wells Fargo sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q4 2022, closing a stake of 69 shares.

Wells Fargo first reported a position in SCPS in Q1 2021 and held it in 6 quarters. The position peaked at $18K in Q1 2021. 1 fund tracked by Wall St. Rank holds SCPS as of Q4 2022.

Wells Fargo reported no remaining Scopus BioPharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Wells Fargo sold 69 Scopus BioPharma Inc. Common Stock shares in Q4 2022.
Wells Fargo first reported a position in Scopus BioPharma Inc. Common Stock in Q1 2021 and held it in 6 quarters.
Wells Fargo's Scopus BioPharma Inc. Common Stock position peaked at $18K in Q1 2021.
1 fund tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q4 2022.

Based on Wells Fargo's 13F filing for Q4 2022, filed 13 Feb 2023.